| Literature DB >> 28865106 |
A W Bianco1, G E Moore2, S D Taylor1.
Abstract
BACKGROUND: While studies have examined bovine dystocia in relation to calf survival, little has been published regarding perinatal morbidity and treatment of newborn calves beyond failure of transfer of passive immunity (FTPI). Neonatal encephalopathy (NE) is a clinical syndrome commonly diagnosed in infants and foals but is poorly described in calves. HYPOTHESIS/Entities:
Keywords: Bovine; Hypoxic; Ischemic; Weak
Mesh:
Year: 2017 PMID: 28865106 PMCID: PMC5697198 DOI: 10.1111/jvim.14821
Source DB: PubMed Journal: J Vet Intern Med ISSN: 0891-6640 Impact factor: 3.333
Univariate analysis (chi‐square or Fisher's exact test, or t‐test [wt]) of selected variables between calves diagnosed with neonatal encephalopathy (NE) (n = 58) and calves without NE (n=142) born in the hospital or presented at <1 week of age between 2005 and 2015
| Variable | N | All Calves n (% of N) | NE Calves n (%) | Non‐NE Calves n (%) |
|
|---|---|---|---|---|---|
| Demographic data | |||||
| Body weight (kg) (μ ± SD) | 171 | 45.2 ± 9.6 | 44.4 ± 7.5 | 0.58 | |
| Sex, number (%) | 192 | 57 | 135 | ||
| Male | 135 (70.3) | 46 (80.7) | 89 (65.9) | 0.041 | |
| Female | 57 (29.7) | 11 (19.3) | 46 (34.1) | ||
| Season of birth, number (%) | 200 | 0.11 | |||
| Winter | 79 (39.5) | 28 (48.3) | 51 (35.9) | ||
| Spring | 101 (50.5) | 23 (40) | 78 (54.9) | ||
| Summer | 15 (7.5) | 4 (6.9) | 11 (7.6) | ||
| Autumn | 5 (2.5) | 3 (5.2) | 2 (1.4) | ||
| Dam parity, number (%) | 131 | 37 | 94 | 0.55 | |
| Primiparous | 96 (73.3) | 26 (70.3) | 70 (74.5) | ||
| Multiparous | 35 (26.7) | 11 (29.7) | 24 (25.5) | ||
| Parturition‐related variables | |||||
| Labor length, number (%) | 159 | 41 | 118 | ||
| <1 h | 15 (9.4) | 2 (4.9) | 13 (11.0) | ||
| 1–6 h | 114 (71.7) | 26 (63.4) | 88 (74.6) | ||
| >6 h | 30 (18.9) | 13 (31.7) | 17 (14.4) | 0.037 | |
| Induction, number (%) | 200 | ||||
| Yes | 34 (17.0) | 7 (12.1) | 27 (19.0) | 0.24 | |
| Dystocia, number (%) | 200 | ||||
| Yes | 145 (72.5) | 49 (84.5) | 96 (67.6) | 0.015 | |
| C‐Section, number (%) | 200 | ||||
| Yes | 117 (58.5) | 32 (55.2) | 85 (59.9) | 0.54 | |
| Calf orientation | 184 | 49 | 135 | ||
| Abnormal | 58 (31.5) | 26 (46.9) | 100 (25.9) | 0.007 | |
| Twin, number (%) | 200 | ||||
| Yes | 14 (7.0) | 7 (12.1) | 7 (4.9) | 0.12 | |
Number of calves for which data were available for a given variable.
Indicates a statistically significant difference between the NE and non‐NE groups.
Multivariate logistic regression analysis of selected variables that were significantly associated with diagnosis of neonatal encephalopathy (NE) in calves after univariate analysis
| Odds Ratio | Std. Error |
|
| 95% Conf. Interval | |
|---|---|---|---|---|---|
| Male sex | 2.01 | 0.85 | 1.65 | 0.099 | 0.88–4.62 |
| Female | 1 | NA | |||
| Labor >6 h | 1.71 | 0.79 | 1.15 | 0.25 | 0.69–4.25 |
| ≤6 h | 1 | NA | |||
| Dystocia | 2.21 | 1.13 | 1.55 | 0.12 | 0.81–6.02 |
| No dystocia | 1 | NA | |||
| Abnormal presentation | 2.14 | 0.81 | 2.01 | 0.044 | 1.02–4.49 |
| Normal | 1 | NA |
Concurrent diseases in calves diagnosed with neonatal encephalopathy (NE) (n = 58) and calves without NE (n = 142) born in the hospital or presented at <1 week of age between 2005 and 2015. Percentages for the 4 disease categories represent the percentage of the total calves in the column
| Variable | N | All calves n (% of N) | NE Calves n (%) | Non‐NE Calves n (%) |
|
|---|---|---|---|---|---|
| Concurrent disease | 200 | 42 (21) | 21 (36.2) | 21 (14.7) | 0.001 |
| Musculoskeletal | 16 (38.1) | 11 (52.4) | 5 (23.8) | ||
| Meconium staining | 11 (26.2) | 1 (4.8) | 10 (47.6) | ||
| Diarrhea | 8 (19.0) | 6 (28.5) | 2 (9.5) | ||
| Pneumonia | 7 (16.7) | 3 (14.3) | 4 (19.0) |
Chi‐square analysis comparing total proportions of calves with concurrent disease in NE and non‐NE groups.
Univariate analysis (chi‐square or Fisher's exact test, or t‐test [wt]) of selected variables of 58 calves diagnosed with neonatal encephalopathy (NE) that survived (n = 45) or did not survive (n = 13) to discharge from the hospital
| Variable | N | All NE Calves n (% of N) | Survivors | Nonsurvivors |
|
|---|---|---|---|---|---|
| Demographic data | |||||
| Body weight (kg) (μ ± SD) | 49 | 46.3 ± 9.6 | 40.2 ± 7.8 | 0.081 | |
| Sex, number (%) | 57 | 44 | 13 | 0.70 | |
| Male | 46 (70.3) | 36 (78.3) | 10 (21.7) | ||
| Female | 11 (29.7) | 8 (72.3) | 3 (27.3) | ||
| Season of birth, number (%) | 58 | 0.63 | |||
| Winter | 28 | 20 (71) | 8 (35.9) | ||
| Spring | 23 | 18 (40) | 5 (54.9) | ||
| Summer | 4 | 4 (6.9) | 0 (0) | ||
| Autumn | 3 | 3 (5.2) | 0 (0) | ||
| Dam parity, number (%) | 37 | 0.044 | |||
| Primiparous | 26 | 18 (69.2) | 8 (30.8) | ||
| Multiparous | 11 | 11 (100.0) | 0 (0) | ||
| Parturition‐related variables | |||||
| Labor length, number (%) | 41 | 0.23 | |||
| <1 h | 2 (4.9) | 2 (100.0) | 0 (0) | ||
| 1–6 h | 26 (63.4) | 21 (80.8) | 5 (19.2) | ||
| >6 h | 13 (31.7) | 10 (76.9) | 3 (23.1) | ||
| Induction, number (%) | 58 | ||||
| Yes | 7 (12.1) | 7 (100) | 0 (0) | 0.33 | |
| Dystocia, number (%) | 58 | ||||
| Yes | 49 (84.5) | 37 (75.5) | 12 (24.5) | 0.67 | |
| C‐Section, number (%) | 58 | ||||
| Yes | 32 (55.2) | 25 (78.1) | 7 (21.9) | 0.91 | |
| Calf orientation | 58 | ||||
| Malpresentation | 23 (46.9) | 16 (69.6) | 7 (30.4) | 0.16 | |
| Twin, number (%) | 58 | ||||
| Yes | 7 (12.1) | 2 (28.6) | 5 (71.4) | 0.005 | |
| Total plasma protein | 43 | 0.22 | |||
| <5 mg/dL | 14 (32.6) | 9 (64.3) | 5 (35.7) | ||
| 5–5.5 mg/dL | 18 (41.9) | 16 (88.8) | 2 (11.1) | ||
| >5.5 mg/dL | 11 (26.6) | 10 (90.9) | 1 (9.1) | ||
Number of calves for which data were available for a given variable.
Indicates a statistically significant difference between the NE and non‐NE groups.
Univariate analysis (chi‐square or Fisher's exact test) of treatments used in 58 calves diagnosed with neonatal encephalopathy (NE) that survived (n = 45) or did not survive (n = 13) to discharge from the hospital
| Treatment | N | All NE Calves n (% of N) | Survivors n (%) | Nonsurvivors n (%) |
|
|---|---|---|---|---|---|
| Antibiotics | 58 | 43 (76.8) | 35 (81.4) | 8 (18.6) | 0.081 |
| Thiamine | 57 | 11 (19.3) | 7 (63.6) | 4 (36.4) | 0.22 |
| Oxygen insufflation | 58 | 7 (12.1) | 5 (71.4) | 2 (28.6) | 0.22 |
| Plasma | 57 | 6 (10.5) | 5 (83.3) | 1 (16.7) | 0.99 |
| Nonsteroidal anti‐inflammatory drugs | 58 | 24 (41.4) | 19 (79.2) | 5 (20.8) | 0.99 |
| Synthetic colostrum | 56 | 42 (75.0) | 34 (81.0) | 8 (19.0) | 0.47 |
| Vitamin E and Selenium | 58 | 19 (32.8) | 15 (78.9) | 4 (21.2) | 0.99 |
| Caffeine | 58 | 7 (12.1) | 6 (85.7) | 1 (14.3) | 0.99 |
Number of calves for which data were available for a given variable.